L26/P-330 Menstrual and Reproductive Factors and Risk of Uterine Leiomyomata after Age 40 in the E3N – Generations French Cohort
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.666 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von S. Hachem und 6 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Do menstrual and reproductive characteristics reflecting lifetime hormonal exposure influence the risk of uterine leiomyomata after age 40? Summary answer Later age at menarche, higher parity, and younger age at first birth were associated with a lower incidence of uterine leiomyomata after age 40. What is known already Uterine leiomyomata are common benign gynaecological tumours. Menstrual and reproductive factors have been linked to their development, reflecting cumulative hormonal exposure across the reproductive life course. Most existing evidence originates from U.S. cohorts, while data from European populations remain limited. In particular, few studies have focused on women over 40 years of age, a period characterised by high incidence before menopause. Consequently, the epidemiology of uterine leiomyomata in European women is still incompletely described, especially regarding the role of menstrual patterns and reproductive history. Robust population-based longitudinal evidence in this demographic remains scarce and poorly characterised across countries settings. Study design, size, duration This population-based prospective cohort study was conducted within the French E3N - Generations cohort, which enrolled women aged 40–65 years in 1990. The present analysis included 64,179 women aged 40 years or older, followed from 1992 to 2008, during which 5,962 incident uterine leiomyomata cases were identified over 932,390 person-years. Participants/materials, setting, methods Participants were women from the E3N–Generations cohort, specifically the first generation of women originally recruited among members of the Mutuelle Générale de l’Éducation Nationale (MGEN), a French health insurance programme for education professionals. Menstrual and reproductive factors were collected through repeated self-administered questionnaires. Incident uterine leiomyomata were identified during follow-up. Associations were estimated using Cox proportional hazards models with age as the underlying time scale, adjusted for relevant sociodemographic, lifestyle, and reproductive factors. Main results and the role of chance Over 932,390 person-years of follow-up, 5,962 incident uterine leiomyomata cases were identified. Later age at menarche was associated with a lower incidence of uterine leiomyomata (hazard ratio [HR] per year increase 0.95, 95% confidence interval [CI] 0.93–0.97). Parity was inversely associated with incidence, with women having three or more births showing a substantially lower risk compared with nulliparous women (HR 0.40, 95% CI 0.18–0.91). Younger age at first full-term pregnancy was also associated with lower incidence, with a stronger reduction observed for earlier ages at first birth (HR 0.64, 95% CI 0.59–0.71 for the oldest versus youngest category). Women reporting irregular menstrual cycles had a slightly higher incidence (HR 1.08, 95% CI 1.00–1.16). Limitations, reasons for caution Uterine leiomyomata were self-reported, which may have introduced misclassification bias, with underreporting of asymptomatic or incidental diagnoses and potential overreporting due to confusion with other gynecological conditions. Incidence estimates may also reflect detection bias, as higher health-care utilization increases opportunities for clinical diagnosis, leading to underascertainment among less-screened women populations. Wider implications of the findings These initial analyses mark the starting point of a broader research program on uterine leiomyomata in Europe. They lay the groundwork for comprehensive investigations leveraging longitudinal data to refine phenotypes, examine life-course determinants, and inform future etiological and prevention-oriented research. Trial registration number No
Zitieren
APA
Hachem, S., Ansaldi, Y., Sylla, F., Gelot, A., Mokraoui, N., Goffin, P., & Kvaskoff, M. (2026). L26/P-330 Menstrual and Reproductive Factors and Risk of Uterine Leiomyomata after Age 40 in the E3N – Generations French Cohort. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.666
Vancouver
Hachem S, Ansaldi Y, Sylla F, Gelot A, Mokraoui N, Goffin P, et al. L26/P-330 Menstrual and Reproductive Factors and Risk of Uterine Leiomyomata after Age 40 in the E3N – Generations French Cohort. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.666
BibTeX
@article{Hachem2026,
author = {Hachem, S. and Ansaldi, Y. and Sylla, F. and Gelot, A. and Mokraoui, N. and Goffin, P. and Kvaskoff, M.},
title = {L26/P-330 Menstrual and Reproductive Factors and Risk of Uterine Leiomyomata after Age 40 in the E3N – Generations French Cohort},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.666}
}
EUVIMED